Kato K - Search Results

1

Y-box binding protein 1/cyclin A1 axis specifically promotes cell cycle progression at G₂/M phase in ovarian cancer.

Murakami Y, Katsuchi D, Matsumoto T, Kanazawa K, Shibata T, Kawahara A, Akiba J, Yanaihara N, Okamoto A, Itamochi H, Sugiyama T, Terada A, Nishio S, Tsuda N, Kato K, Ono M, Kuwano M. Murakami Y, et al. Among authors: kato k. Sci Rep. 2024 Sep 17;14(1):21701. doi: 10.1038/s41598-024-72174-9. Sci Rep. 2024. PMID: 39289424 Free PMC article.

2

Medroxyprogesterone acetate inhibits proliferation of colon cancer cell lines by modulating cell cycle-related protein expression.

Tanaka Y, Kato K, Mibu R, Uchida S, Asanoma K, Hashimoto K, Nozaki M, Wake N. Tanaka Y, et al. Among authors: kato k. Menopause. 2008 May-Jun;15(3):442-53. doi: 10.1097/gme.0b013e318156fb77. Menopause. 2008. PMID: 18202593

3

High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.

Yoshihara K, Tsunoda T, Shigemizu D, Fujiwara H, Hatae M, Fujiwara H, Masuzaki H, Katabuchi H, Kawakami Y, Okamoto A, Nogawa T, Matsumura N, Udagawa Y, Saito T, Itamochi H, Takano M, Miyagi E, Sudo T, Ushijima K, Iwase H, Seki H, Terao Y, Enomoto T, Mikami M, Akazawa K, Tsuda H, Moriya T, Tajima A, Inoue I, Tanaka K; Japanese Serous Ovarian Cancer Study Group. Yoshihara K, et al. Clin Cancer Res. 2012 Mar 1;18(5):1374-85. doi: 10.1158/1078-0432.CCR-11-2725. Epub 2012 Jan 12. Clin Cancer Res. 2012. PMID: 22241791

4

Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer.

Yoneda T, Kuboyama A, Kato K, Ohgami T, Okamoto K, Saito T, Wake N. Yoneda T, et al. Among authors: kato k. Oncol Rep. 2013 Jul;30(1):25-34. doi: 10.3892/or.2013.2433. Epub 2013 Apr 29. Oncol Rep. 2013. PMID: 23624782 Free PMC article.

5

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.

Sugiyama T, Okamoto A, Enomoto T, Hamano T, Aotani E, Terao Y, Suzuki N, Mikami M, Yaegashi N, Kato K, Yoshikawa H, Yokoyama Y, Tanabe H, Nishino K, Nomura H, Kim JW, Kim BG, Pignata S, Alexandre J, Green J, Isonishi S, Terauchi F, Fujiwara K, Aoki D. Sugiyama T, et al. Among authors: kato k. J Clin Oncol. 2016 Aug 20;34(24):2881-7. doi: 10.1200/JCO.2016.66.9010. Epub 2016 Jul 11. J Clin Oncol. 2016. PMID: 27400948 Clinical Trial.

6

MicroRNA-135a-3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer.

Fukagawa S, Miyata K, Yotsumoto F, Kiyoshima C, Nam SO, Anan H, Katsuda T, Miyahara D, Murata M, Yagi H, Shirota K, Yasunaga S, Kato K, Miyamoto S. Fukagawa S, et al. Among authors: kato k. Cancer Sci. 2017 May;108(5):886-896. doi: 10.1111/cas.13210. Epub 2017 May 22. Cancer Sci. 2017. PMID: 28231414 Free PMC article.

7

Dual-specificity phosphatase 6 plays a critical role in the maintenance of a cancer stem-like cell phenotype in human endometrial cancer.

Kato M, Onoyama I, Yoshida S, Cui L, Kawamura K, Kodama K, Hori E, Matsumura Y, Yagi H, Asanoma K, Yahata H, Itakura A, Takeda S, Kato K. Kato M, et al. Among authors: kato k. Int J Cancer. 2020 Oct 1;147(7):1987-1999. doi: 10.1002/ijc.32965. Epub 2020 Mar 26. Int J Cancer. 2020. PMID: 32159851 Free PMC article.

8

YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer.

Suzuki I, Yoshida S, Tabu K, Kusunoki S, Matsumura Y, Izumi H, Asanoma K, Yagi H, Onoyama I, Sonoda K, Kohno K, Taga T, Itakura A, Takeda S, Kato K. Suzuki I, et al. Among authors: kato k. Sci Rep. 2021 Feb 18;11(1):4220. doi: 10.1038/s41598-021-83200-5. Sci Rep. 2021. PMID: 33602962 Free PMC article.

9

Mitochondrial dysfunction-induced high hCG associated with development of fetal growth restriction and pre-eclampsia with fetal growth restriction.

Kiyokoba R, Uchiumi T, Yagi M, Toshima T, Tsukahara S, Fujita Y, Kato K, Kang D. Kiyokoba R, et al. Among authors: kato k. Sci Rep. 2022 Mar 8;12(1):4056. doi: 10.1038/s41598-022-07893-y. Sci Rep. 2022. PMID: 35260712 Free PMC article.

10

Study of the effects of in-person attendance at academic conferences on the health of the attendees under COVID-19 pandemic.

Yahata H, Kato K, Shimokawa M, Kawamura K, Shimono N, Kawana K, Okamoto A, Aoki D, Kimura T. Yahata H, et al. Among authors: kato k. J Obstet Gynaecol Res. 2023 Apr;49(4):1083-1089. doi: 10.1111/jog.15626. Epub 2023 Feb 22. J Obstet Gynaecol Res. 2023. PMID: 36812688

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,896 results

Search Page

Filters